These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 8112131)
1. [Preparation of monoclonal antibodies against ovarian carcinoma bearing chemical drugs entrapped in liposomes and the cytotoxic tests to carcinoma cells]. Li WJ Zhonghua Fu Chan Ke Za Zhi; 1993 Oct; 28(10):604-7, 635-6. PubMed ID: 8112131 [TBL] [Abstract][Full Text] [Related]
2. Target therapy of ovarian carcinoma by monoclonal antibodies bearing chemical drugs entrapped in liposomes. Qian HN; Li WJ Chin Med J (Engl); 1993 May; 106(5):343-7. PubMed ID: 8404276 [TBL] [Abstract][Full Text] [Related]
3. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposomes and adriamycin]. Li WJ; Qian HN; Lu WY Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):539-41, 582. PubMed ID: 7842351 [TBL] [Abstract][Full Text] [Related]
4. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposome and adriamycin]. Li WJ; Qian HN; Lu WY Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):296-8, 319. PubMed ID: 7956556 [TBL] [Abstract][Full Text] [Related]
5. [Production of adriamycin covalent binding to monoclonal antibody OC-859 and its anti-tumor activities]. Zhang L Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):346-8, 387. PubMed ID: 1804604 [TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. Ahmad I; Allen TM Cancer Res; 1992 Sep; 52(17):4817-20. PubMed ID: 1511445 [TBL] [Abstract][Full Text] [Related]
7. Anti-idiotypic monoclonal antibodies against anti-ovarian carcinoma monoclonal antibody COC166-9. Generation and application. Qian HN; Lu WY Chin Med J (Engl); 1994 Feb; 107(2):99-103. PubMed ID: 8194388 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies. Ohta S; Igarashi S; Honda A; Sato S; Hanai N Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Lopes de Menezes DE; Pilarski LM; Allen TM Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662 [TBL] [Abstract][Full Text] [Related]
10. Effect of adriamycin entrapped by sulfatide-containing liposomes on ovarian tumor-bearing nude mice. Kojima N; Ueno N; Takano M; Yabushita H; Noguchi M; Ishihara M; Yagi K Biotechnol Appl Biochem; 1986 Oct; 8(5):471-8. PubMed ID: 3768148 [TBL] [Abstract][Full Text] [Related]
11. [Targeting cancer chemotherapy using temperature-sensitive liposomes containing adriamycin conjugated with monoclonal antibodies]. Shibata S; Kumai K; Takahashi T; Murayama Y; Ishibiki K; Kitajima M Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1671-4. PubMed ID: 1530328 [TBL] [Abstract][Full Text] [Related]
12. Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance. Leveille-Webster CR; Arias IA Clin Cancer Res; 1996 Apr; 2(4):695-706. PubMed ID: 9816220 [TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein expression in ovarian cancer cell line following treatment with cisplatin. Yang X; Pagé M Oncol Res; 1995; 7(12):619-24. PubMed ID: 8704279 [TBL] [Abstract][Full Text] [Related]
14. [The internalization of immunotargeting drugs for hepatocellar carcinoma and its significance]. Sui Y; Sun Z; Chen Z Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):845-7. PubMed ID: 9275537 [TBL] [Abstract][Full Text] [Related]
15. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin. O'Neill CF; Koberle B; Masters JR; Kelland LR Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725 [TBL] [Abstract][Full Text] [Related]
16. Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker. Greenfield RS; Kaneko T; Daues A; Edson MA; Fitzgerald KA; Olech LJ; Grattan JA; Spitalny GL; Braslawsky GR Cancer Res; 1990 Oct; 50(20):6600-7. PubMed ID: 2208122 [TBL] [Abstract][Full Text] [Related]
17. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma]. Zhu L; Lang J; Shen K Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738 [TBL] [Abstract][Full Text] [Related]
18. Experimental study on the mechanism of cisplatin resistance and its reversion in human ovarian cancer. Liang Z; Bian D Chin Med J (Engl); 1996 May; 109(5):353-5. PubMed ID: 9208490 [TBL] [Abstract][Full Text] [Related]
19. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells. Villedieu M; Louis MH; Dutoit S; Brotin E; Lincet H; Duigou F; Staedel C; Gauduchon P; Poulain L Gynecol Oncol; 2007 Apr; 105(1):31-44. PubMed ID: 17275076 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activity and cellular processing in human ovarian carcinoma cell lines of a new platinum(II) compound containing a fluorescent substituted propylene diamine ligand. Marqués-Gallego P; den Dulk H; Brouwer J; Tanase S; Mutikainen I; Turpeinen U; Reedijk J Biochem Pharmacol; 2009 Aug; 78(4):365-73. PubMed ID: 19413998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]